Compounds > promegestone
Page last updated: 2024-08-23

promegestone and Endometrial Neoplasms

promegestone has been researched along with Endometrial Neoplasms in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (33.33)18.2507
2000's3 (33.33)29.6817
2010's3 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, JJ; Lee, II; Lydon, JP; Maniar, K1
Amazit, L; Bellance, C; Guiochon-Mantel, A; Khan, JA; Lombès, M; Loosfelt, H1
Kim, JJ; Lee, II; Lu, Z; Pant, A; Rueda, BR; Schink, J1
Blok, LJ; Brinkmann, AO; Burger, CW; Helmerhorst, TJ; Huikeshoven, FJ; Kühne, LC; Smid-Koopman, E1
Chao, V; Dreher, E; Mueller, MD; Pritts, EA; Taylor, RN; Vigne, JL1
Chen, CL; Liao, QP; Lu, Y; Yu, L1
Arnold, SF; Klotz, DM; McLachlan, JA1
Hata, H; Kuramoto, H1
Cabrera, JJ; Chirino, R; Falcón, O; Fernández, L; Fernández, P; Jiménez, P; León, L; López, A; Navarro, D; Rivero, JF1

Other Studies

9 other study(ies) available for promegestone and Endometrial Neoplasms

ArticleYear
Akt regulates progesterone receptor B-dependent transcription and angiogenesis in endometrial cancer cells.
    Oncogene, 2016, 09-29, Volume: 35, Issue:39

    Topics: Animals; Cell Line, Tumor; Endometrial Neoplasms; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 3-Ring; Humans; Mice; Neovascularization, Pathologic; Progestins; Promegestone; Proto-Oncogene Proteins c-akt; Receptors, Progesterone; Transcription, Genetic

2016
p38 and p42/44 MAPKs differentially regulate progesterone receptor A and B isoform stabilization.
    Molecular endocrinology (Baltimore, Md.), 2011, Volume: 25, Issue:10

    Topics: Breast Neoplasms; Cell Line, Tumor; Endometrial Neoplasms; Female; Gonanes; Humans; Ligands; MAP Kinase Kinase Kinase 1; Mifepristone; Mitogen-Activated Protein Kinase 1; Models, Biological; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Phosphoserine; Promegestone; Proteasome Endopeptidase Complex; Protein Isoforms; Protein Stability; Receptors, Progesterone; Transcription, Genetic

2011
Inhibition of AKT with the orally active allosteric AKT inhibitor, MK-2206, sensitizes endometrial cancer cells to progestin.
    PloS one, 2012, Volume: 7, Issue:7

    Topics: Administration, Oral; Allosteric Site; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Endometrial Neoplasms; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 3-Ring; Humans; Mice; Mice, Nude; Progestins; Promegestone; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Receptors, Progesterone; Remission Induction

2012
Distinct functional differences of human progesterone receptors A and B on gene expression and growth regulation in two endometrial carcinoma cell lines.
    Journal of the Society for Gynecologic Investigation, 2003, Volume: 10, Issue:1

    Topics: Cell Division; Endometrial Neoplasms; Female; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Medroxyprogesterone Acetate; Progesterone; Progesterone Congeners; Promegestone; Receptors, Progesterone; Transfection; Tumor Cells, Cultured

2003
Progestins activate vascular endothelial growth factor gene transcription in endometrial adenocarcinoma cells.
    Fertility and sterility, 2003, Volume: 79, Issue:2

    Topics: Adenocarcinoma; Endometrial Neoplasms; Endothelial Growth Factors; Female; Gene Expression Regulation, Neoplastic; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Medroxyprogesterone; Mifepristone; Promegestone; Receptors, Progesterone; Transcription, Genetic; Transfection; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2003
[Functional study of progesterone receptor isoforms in endometrial cancer cell lines].
    Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2006, Oct-18, Volume: 38, Issue:5

    Topics: Adenocarcinoma; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Endometrial Neoplasms; Estradiol; Female; Humans; Mifepristone; Oligodeoxyribonucleotides, Antisense; Promegestone; Receptors, Progesterone; Transfection

2006
Inhibition of 17 beta-estradiol and progesterone activity in human breast and endometrial cancer cells by carbamate insecticides.
    Life sciences, 1997, Volume: 60, Issue:17

    Topics: Binding, Competitive; Breast Neoplasms; Carbamates; Endometrial Neoplasms; Estradiol; Estrogen Antagonists; Female; Humans; Insecticides; Luciferases; Progesterone; Progesterone Congeners; Promegestone; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured; Uterine Neoplasms

1997
Immunocytochemical determination of estrogen and progesterone receptors in human endometrial adenocarcinoma cells (Ishikawa cells).
    The Journal of steroid biochemistry and molecular biology, 1992, Volume: 42, Issue:2

    Topics: Adenocarcinoma; Animals; Cell Nucleus; Endometrial Neoplasms; Estradiol; Female; Immunohistochemistry; Promegestone; Rats; Receptors, Estrogen; Receptors, Progesterone; Staining and Labeling; Tumor Cells, Cultured

1992
Endometrial stromal sarcoma expression of estrogen receptors, progesterone receptors and estrogen-induced srp27 (24K) suggests hormone responsiveness.
    The Journal of steroid biochemistry and molecular biology, 1992, Volume: 41, Issue:3-8

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line; Cytosol; Endometrial Neoplasms; Endometrium; Estradiol; Estrogen Antagonists; Female; Heat-Shock Proteins; Humans; Immunohistochemistry; Promegestone; Receptors, Estrogen; Receptors, Progesterone; Reference Values; Sarcoma

1992